These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7880744)
1. Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin. Stewart DJ; Molepo JM; Green RM; Montpetit VA; Hugenholtz H; Lamothe A; Mikhael NZ; Redmond MD; Gadia M; Goel R Br J Cancer; 1995 Mar; 71(3):598-604. PubMed ID: 7880744 [TBL] [Abstract][Full Text] [Related]
2. Platinum concentrations in human autopsy tumor samples. Stewart DJ; Mikhael NZ; Nair RC; Kacew S; Montpetit V; Nanji A; Maroun JA; Howard K Am J Clin Oncol; 1988 Apr; 11(2):152-8. PubMed ID: 3358362 [TBL] [Abstract][Full Text] [Related]
3. Uptake and retention of platinum in patients undergoing cisplatin therapy. Jonson R; Börjesson J; Mattsson S; Unsgaard B; Wallgren A Acta Oncol; 1991; 30(3):315-9. PubMed ID: 2036240 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin and radiation in the treatment of tumors of the central nervous system: pharmacological considerations and results of early studies. Stewart DJ; Molepo JM; Eapen L; Montpetit VA; Goel R; Wong PT; Popovic P; Taylor KD; Raaphorst GP Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):531-42. PubMed ID: 8276672 [TBL] [Abstract][Full Text] [Related]
5. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma. Nakashima M; Shibata S; Tokunaga Y; Fujita H; Anda T; Arizono K; Tomiyama N; Sasaki H; Ichikawa M J Pharm Pharmacol; 1997 Aug; 49(8):777-80. PubMed ID: 9379355 [TBL] [Abstract][Full Text] [Related]
6. Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck. Holding JD; Lindup WE; Bowdler DA; Siodlak MZ; Stell PM Br J Clin Pharmacol; 1991 Aug; 32(2):173-9. PubMed ID: 1931468 [TBL] [Abstract][Full Text] [Related]
7. Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration. Stewart DJ; Dulberg C; Molepo JM; Mikhael NZ; Montpetit VA; Redmond MD; Goel R Cancer Chemother Pharmacol; 1994; 34(1):14-22. PubMed ID: 8174197 [TBL] [Abstract][Full Text] [Related]
8. Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution. Deurloo MJ; Kop W; van Tellingen O; Bartelink H; Begg AC Cancer Chemother Pharmacol; 1991; 27(5):347-53. PubMed ID: 1998994 [TBL] [Abstract][Full Text] [Related]
9. Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile. Petrovic NS; Grujicic D; Artiko VM; Sobic-Saranovic DP; Gajic MM; Jaksic E; Grajic MM; Antonovic OJ; Petrovic MN; Obradovic VB Nucl Med Commun; 2010 Nov; 31(11):962-73. PubMed ID: 20802363 [TBL] [Abstract][Full Text] [Related]
10. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin. Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212 [TBL] [Abstract][Full Text] [Related]
11. [Platinum concentrations in human tissue after administration of cisplatin]. Tochigi T; Ono K; Yoshikawa K; Hoshi S; Orikasa S; Imai Y Gan To Kagaku Ryoho; 1988 Feb; 15(2):269-75. PubMed ID: 3341789 [TBL] [Abstract][Full Text] [Related]
12. Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity. Stewart DJ; Mikhael NZ; Nanji AA; Nair RC; Kacew S; Howard K; Hirte W; Maroun JA J Clin Oncol; 1985 Sep; 3(9):1251-6. PubMed ID: 4040958 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of platinum in cancer patients treated with cisplatin at different doses. Fracasso ME; Apostoli P; Benoni G; Bonetti A; Griso C; Leone R Drugs Exp Clin Res; 1987; 13(6):367-72. PubMed ID: 3652926 [TBL] [Abstract][Full Text] [Related]
14. Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews. Eiseman JL; Beumer JH; Rigatti LH; Strychor S; Meyers K; Dienel S; Horn CC Cancer Chemother Pharmacol; 2015 Jan; 75(1):143-52. PubMed ID: 25398697 [TBL] [Abstract][Full Text] [Related]
15. Gamma camera imaging of platinum in tumours and tissues of patients after administration of 191Pt-cisplatin. Areberg J; Björkman S; Einarsson L; Frankenberg B; Lundqvist H; Mattsson S; Norrgren K; Scheike O; Wallin R Acta Oncol; 1999; 38(2):221-8. PubMed ID: 10227445 [TBL] [Abstract][Full Text] [Related]
16. C-erbB2/HER2 in human gliomas, medulloblastomas, and meningiomas: a minireview. Waage IS; Vreim I; Torp SH Int J Surg Pathol; 2013 Dec; 21(6):573-82. PubMed ID: 23842006 [TBL] [Abstract][Full Text] [Related]
17. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects. Hohnloser JH; Schierl R; Hasford B; Emmerich B Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151 [TBL] [Abstract][Full Text] [Related]
18. [An autopsy case of rectal cancer receiving cisplatin at total dose of 3.250 mg and platinum concentrations in autopsy tissue samples]. Ishigaki H; Satoh S; Saitoh S; Yoshida Y; Ebina T; Satoh T; Nara K; Asano M; Oh-ishi S; Satoh F Gan To Kagaku Ryoho; 1989 Dec; 16(12):3805-8. PubMed ID: 2596863 [TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of carboplatin. van der Vijgh WJ Clin Pharmacokinet; 1991 Oct; 21(4):242-61. PubMed ID: 1760899 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic differences between rat tumour and lung tissues following isolated lung perfusion with cisplatin. Li TS; Kaneda Y; Saeki K; Ueda K; Zempo N; Esato K Eur J Cancer; 1999 Dec; 35(13):1846-50. PubMed ID: 10674002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]